Delivery Order SPE2DB20D3103-SPE2DB22FM3F0

Award Date 1/18/22
Potential Completion Date 1/19/22
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Emgality 120 mg/mL pen-injectors to the Defense Logistics Agency (DLA). The $1,097.14 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of September 20, 2022 and was awarded on September 19, 2022. It does not have a set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.00 firm fixed-price delivery order is for the medication Emgality 120 mg/ml pen injector, and has a completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,739.03, is for the supply of Emgality 120 mg/ml pen injectors. It is a firm fixed-price contract with an ultimate completion date of April 13, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,132.93 Firm Fixed Price Delivery Order (Contract # SPE2DX15D3005|SPE2DX24F3SXB) is for the supply of Emgality 120 mg/ml pen injectors. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,642.29 firm-fixed-price delivery order is for the supply of Emgality 120 mg/ml pen-injectors, a prescription medication used for the treatment of migraine. The award has an ultimate completion date of November 13, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the delivery of Emgality 120 mg/ml pen injectors to the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. The contract, valued at $3,175.43, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract has no set-aside designation and is a Firm Fixed Price Delivery Order with an ultimate completion date of June 18, 2024. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,097.06 firm fixed-price delivery order is for the pharmaceutical product Emgality 120 mg/ml penml. The contract has a completion date of September 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to supply a wide range of medications and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,289.75 Firm Fixed Price Delivery Order covers the supply of Emgality 120 mg/ml injectable medication. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.40 firm fixed-price delivery order is for the supply of Emgality 120 mg/ml pens and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,667 firm fixed-price delivery order is for the supply of Emgality 120 mg/ml injectable medication, with a completion date of May 26, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FM3F0
    Delivery Order

This federal contract award is for the delivery of Emgality 120 mg/ml pen injectors to the Defense Logistics Agency (DLA). The $1,449.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 19, 2022.

AmerisourceBergen is a major pharmaceutical distributor that supplies a wide range of medical products, including specialty medications, generic drugs, and medical devices, to various government agencies. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering pharmaceutical and medical supplies to support military healthcare programs globally. Additionally, AmerisourceBergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating it was awarded through full and open competition. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the provision of essential pharmaceutical and medical commodities.

Generated 2/27/25, 12:28 PM